103 related articles for article (PubMed ID: 38722212)
1. Delineating genotype and parent-of-origin effect on the phenotype in MSH6-associated Lynch syndrome.
van der Werf-'t Lam AS; Rodriguez-Girondo M; Villasmil M; Tops CM; van Hest L; Gille HJP; Duijkers FAM; Wagner A; Eikenboom E; Letteboer TGW; de Jong MM; Bajwa-Ten Broeke SW; Bleeker F; Gomez Garcia EB; Dominguez-Valentin M; Møller P; Suerink M; Nielsen M
Genes Chromosomes Cancer; 2024 May; 63(5):e23237. PubMed ID: 38722212
[TBL] [Abstract][Full Text] [Related]
2. Risks of Lynch syndrome cancers for MSH6 mutation carriers.
Baglietto L; Lindor NM; Dowty JG; White DM; Wagner A; Gomez Garcia EB; Vriends AH; ; Cartwright NR; Barnetson RA; Farrington SM; Tenesa A; Hampel H; Buchanan D; Arnold S; Young J; Walsh MD; Jass J; Macrae F; Antill Y; Winship IM; Giles GG; Goldblatt J; Parry S; Suthers G; Leggett B; Butz M; Aronson M; Poynter JN; Baron JA; Le Marchand L; Haile R; Gallinger S; Hopper JL; Potter J; de la Chapelle A; Vasen HF; Dunlop MG; Thibodeau SN; Jenkins MA
J Natl Cancer Inst; 2010 Feb; 102(3):193-201. PubMed ID: 20028993
[TBL] [Abstract][Full Text] [Related]
3. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
4. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
[TBL] [Abstract][Full Text] [Related]
6. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
Obermair A; Youlden DR; Young JP; Lindor NM; Baron JA; Newcomb P; Parry S; Hopper JL; Haile R; Jenkins MA
Int J Cancer; 2010 Dec; 127(11):2678-84. PubMed ID: 20533284
[TBL] [Abstract][Full Text] [Related]
7. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
Stoffel E; Mukherjee B; Raymond VM; Tayob N; Kastrinos F; Sparr J; Wang F; Bandipalliam P; Syngal S; Gruber SB
Gastroenterology; 2009 Nov; 137(5):1621-7. PubMed ID: 19622357
[TBL] [Abstract][Full Text] [Related]
8. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
10. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract][Full Text] [Related]
11. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract][Full Text] [Related]
12. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
13. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
14. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
[TBL] [Abstract][Full Text] [Related]
15. A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report.
Walker R; Clendenning M; Joo JE; Xue J; Mahmood K; Georgeson P; Como J; Joseland S; Preston SG; Chan JM; Jenkins MA; Rosty C; Macrae FA; Di Palma S; Campbell A; Winship IM; Buchanan DD
Fam Cancer; 2023 Oct; 22(4):423-428. PubMed ID: 37318702
[TBL] [Abstract][Full Text] [Related]
16. Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers.
van der Werf-'t Lam AS; Terlouw D; Tops CM; van Kan MS; van Hest LP; Gille HJP; Duijkers FAM; Wagner A; Eikenboom EL; Letteboer TGW; de Jong MM; Bajwa-Ten Broeke SW; Bleeker FE; Gomez Garcia EB; de Wind N; van Wezel JT; Morreau H; Suerink M; Nielsen M
Mod Pathol; 2023 Sep; 36(9):100240. PubMed ID: 37307877
[TBL] [Abstract][Full Text] [Related]
17. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population.
Castellsagué E; Liu J; Volenik A; Giroux S; Gagné R; Maranda B; Roussel-Jobin A; Latreille J; Laframboise R; Palma L; Kasprzak L; Marcus VA; Breguet M; Nolet S; El-Haffaf Z; Australie K; Gologan A; Aleynikova O; Oros-Klein K; Greenwood C; Mes-Masson AM; Provencher D; Tischkowitz M; Chong G; Rousseau F; Foulkes WD
Clin Genet; 2015 Jun; 87(6):536-42. PubMed ID: 25318681
[TBL] [Abstract][Full Text] [Related]
19. Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in Lynch syndrome.
Bogani G; Ricci MT; Vitellaro M; Ditto A; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2019 May; 29(4):705-710. PubMed ID: 30772826
[TBL] [Abstract][Full Text] [Related]
20. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
